ML20235D517

From kanterella
Jump to navigation Jump to search
Amend 2 to License 50-23214-01 for Anchorage Diagnostic Imaging Ctr,Designating Hf Cable as Radiation Safety Officer to Use & Supervise Use of 30 Mci I-131 & Any 10CFR35.100,200 & 10CFR31.11 Byproduct Matl for Listed Medical Uses
ML20235D517
Person / Time
Site: 03020372
Issue date: 12/28/1987
From: Riedlinger B
NRC OFFICE OF INSPECTION & ENFORCEMENT (IE REGION V)
To:
Shared Package
ML20235D520 List:
References
50-23214-01, 50-23214-1, NUDOCS 8902170469
Download: ML20235D517 (2)


See also: IR 05000232/2014001

Text

___ _ _ _ _ _ _ , , _ _ _ _ . . _ _ _ _ _ _ _ _ _

_ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ . _ _ _ _ _ _ _ _ . _ _ _ _ _ _ _ _ _ _ _ _ ________

a m,- yuw a m m m = = = m = = = = = = m m m m m m m m m m m m m m m m m m m m m m m m m m m m m m m m m q

-

NZC Fwm 374 - 1 2 g

(3 83)# PAGE OF PAGES

U.S. NUCLEAR REGULATORY COMMISSION

Amendment No. 2

- MATERIALS LICENSE ,

'

Pursuant to the Atomic Energy Act of 1954, as amended, the Energy Reorganization Act of 1974 (Public Law 93-438). and Title 10,

Code of Federal Regulations, Chapter I, Parts 30,31,32,33,34,35,40 and 70 and in reliance on statements and representations y

heretofore made by the licensee, a license is hereby issued authorizing the licensee to receive, acquire, possess, and transfer byproduct,

source, and special nuclear material designated below; to use such material for the purpose (s) and at the place (s) designated below; to

deliver or transfer such material to persons authorized to receive it in accordance with the regulations of the applicable Part(s). This

license shall be deemed to contain the conditions specified in Section 183 of the Atomic Energy Act of 1954, as amended, and is

rubject to all applicable rules, regulations and orders of the Nuclear Regulatory Commission now or hereafter in effect and to any

,

conditions specified below. y

Licensee

i

,

1. Anchorage Diagnostic Imaging Center

dba Diagnostic Radiology Associates

3. IJeense number 50-23214-01

[

l 2. 4003 Lake Otis Parkway, #101 l J, j ,

Anchorage, Alaska 99508 s h. g*@ 4. 6piration date August 31, 1989

'

<\*([ 5. Docket or

Reference No.

N +

030-20372  !

,

, 6. Byproduct, source,and/or

special nuclear material

A 7. Chemical and/or physical

,, S, Maximum

U.

may possess at amount

any one timethat license

)

N. form

Q Dx

,,- ,, yif #under

,,

~ this license >

A. Any byproduct materihl N'r\  % A. Any radiopharmaceutical ,q A. As needed

l

p

identified in 10 CFR 35.100pb> ,e j qqg

j' identified inp10iCFR q 35.100b *

Any byproductebial mat"g<

B.

identifiedin10(CFR35.200, sA p' Bi(% identified [in(10 CFR 35 200l <

, IAnyIradi$ pharmac'eutical

.

DB. As needed

N

C.

.

Iodine-131

ej)

' Qd) %

oMC.WIodide$gfilAlA

%bir  %

lb

N O' Y 30 millicuries

>

>

n 7N[ d[l$$j!b Y [e C . As needed l

D. Any byproduct material QDNf Prep'ackaged ' Kits * p ' D. y

identified in 10 CFRi31.11 QAui~,fjjA7;g N

J uton\ \ :w . V.M)f.

9. Authorized use: ^< ;f) , 141 w X L.

'

,Qm m

ve a l

A. Medical use described in 10 CFR f 35.100. ,J ,

B. Medical use described in 10 CFR<35.200. , R ,

C. Diagnosis and treatment of hypefthy'roidis#m ' "'

and[ '

car'diac dysfunction.

D. In vitro studies.

CONDITIONS

10. Location of use: 4003 Lake Otis Parkway, Anchorage, Alaska

11. Radiation Safety Officer: Dr. Harold F. Cable N

N

12. Authorized users:

A. James D. Pister, M.D. for materials identified in 10 CFR 35.100, 35.200, p

31.11, and 1-131 for treatment of hyperthyroidism or cardiac dysfunction. p

>

B. Gerald H. Phillips, M.D. for materials identified in 10 CFR 35.100, 35.200, N'

31.11, and 1-131 for treatment of hyperthyroidism or cardiac dysfunction. $

C. Harold F. Cable, M.D. for materials identified in 10 CFR 35.100, 35.200,

jl

f

31.11, and I-131 for treatment of hyperthyroidism or cardiac dysfunction. F

8902170469 871228 __ __

__d kj

REQ 5 LIC30 Emamsgammamamarasammmmmaussammurmamwmas

50-23214-01 PNU

__ __

_ .. __ _ _ __ _

_ . _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ . _ _ _ _ _ ,

gu m amsm mm m m m mmmmmmmuumLmmmm = = - m-mm m - - - m m mm m mmmmmmLmmtammm mmmmy

l NRC Form 374A U.S. NUCLEAR RE!ULATCRY COMMISSION PAGE OF PAGES  !

l 4 84 Licen arumber I

i 50-23214-01 I

i -

MATERIALS LICENSE Docket or Reference number

l

I * SUPPLEMENTARY SHEET 030-20372 I

I .

I

I i

, Amendment No. 2 l

l l

l 1

l CONDITIONS I

I

(continued) E

'

~13. This license is based on the licensee's statements and representations in the l

l following documents:

p

y

I i

i A. Application dated July 23, 1984 I

I B. Letter dated August 15, 1984 8

C. Letter' dated August 18, 1987

l D. Letter dated December 8, 1987 ly

,

l y'. hp* {g p- (33 ,r~.j'e,

S

i

I (~ ,g w >g

,

I ,,, s - %Q, /* ,u I

p

i, @+ 3

I

gm

"*

e/

y

s

y

I

s _, <O

&, y ns ,- / <j

l  !.; ~;.m e ~. l

l  %!q, * /. -fm,< h

j f

% ,. ? ..

g

Q t.; h.\ ,.- .. j Ulp '

'

r" "*) l

,- r~ ,1 ., q ,-

1 ',g;#;

s,

,

py,

~ .

g "'-

.+ f / ,N' -'

g

I f .e

x,'

'a \. s i f L ,/ ):; f

t. \ .- s

>

,

i ,

f

-

"

~ , ,

y t~ O - ,

..) c. , c; p

t di Ea f- ~i

N

i-

i

0+

1;b

>:y:q p

C%gj{Nf asJ!I Egy h( i :.{n W: ~{ r dls #; <, J

yr . ,.;; e ,L , p

h

a ;g.j_ ec J.C .- -91 S &?uf @ Py8y'}f;: %n l

- r . w' "

,

> y-

,

l  ; p-c 4 # ,X A. ..

g

g --

.' 4 .

y q. .

p

j '

,

C Cl , 3

s ., .) [rj  %: l

g j, 'C g  %

(;% n

,! eg, p> i

'

,g>

! s4 -

.

6-

g  : ~

.%. p

y

L, p ,

g . .; p p

g FOR THE U.S. NUCLEAR REGULATORY COMMISSION p

i i  !

9 original signed by B, A. Riedlinger E '

Date December 28, 1987 By

'

l

q Beth A. Riedlinger l1

p

q Health Physicist (Licensing) 'A

p Nuclear Materials Safety Section N

E Region V N

4 1

!

!

g

! N

4 >

N P

l 4 >

l h

h

,

i P ,

'

d M

kfKwrasswhrdKmaussamawammmraarawsausawawns#YdKYMM

-_